Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2025-12-24 @ 11:36 PM
NCT ID:
NCT01456156
Eligibility Criteria:
Inclusion Criteria:
* written informed consent provided
* 18\~75 years old
* patients with histopathological proved hepatocellular carcinoma received hepatectomy and had at least one risk factor of recurrence
* without any lymph node or distant metastasis (any T N0M0)
* liver function: Child-Pugh A or B
* Performance status: Karnofsky (KPS)≥70 or world health organization(WHO) score 0,1
* life expectation\>6 months
* no dysfunction of major organs
* no prior radiotherapy
* negative for human immunodeficiency virus syndrome (HIV)
* Considerable to computed tomography(CT) simulation and 3D-CRT or IMRT
Exclusion Criteria:
* malignant tumors of other sits
* combining severe diseases, such as acute myocardial infarction(AMI), arrhythmias, infection
* surgery performed in other hospitals without details
* pregnant woman or woman need to breast feed or woman with positive chorionic gonadotrophin (HCG)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT01456156
Study Brief:
Protocol Section:
NCT01456156